175P An analysis on the prognostic value of OST: An immune-mediated toxicity grading tool - in a melanoma cohort
Immune-related adverse events (irAEs) are toxicities associated with immune checkpoint inhibitors (ICIs), and may correlate to better survival. This study examines the prognostic value of a novel toxicity scoring tool (OST6) in a melanoma cohort.
Authors
- F-X. Danlos
- A. Fitzpatrick
- S. Ghuman
- O. Lambotte
- M. Fitzpatrick-Greening
- A. Marabelle
- A. Cope
- Y. Wu
- J-M. Michot
- V. Stewart
- M. Kapiris
- X. Mariette
- A. Laparra-Ramakichenin
- S. Bratsos
- S. Messayke
- M. Harries
- S. Bitoun
- D. Sarker
- A. Santaolalla
Institutions
- Guy's Hospital (GB)
- Inserm (FR)
- King's College London (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Institut Gustave Roussy (FR)
- London Cancer (GB)
- Assistance Publique – Hôpitaux de Paris (FR)
- King's College School (GB)
- King's College Hospital (GB)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- Immuno-Oncology Technology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1016/j.iotech.2025.101258
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00